Efficacy End Points and Dose Analysis of Food and Drug Administration-Approved Novel Drugs in 2020
ABSTRACT: Background: During 2020, the Food and Drug Administration approved 53 novel drugs. Objective: Biomarkers, surrogate endpoints and dosing regimens used in early and pivotal clinical stages are evaluated. Methods: Information on various efficacy end points of 2020 Food and Drug Administrati...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-01-01
|
| Series: | Current Therapeutic Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X22000194 |